Skip to Content

← See all SENEXON-S brands

SENEXON-S by NCS HealthCare of KY, Inc dba Vangard Labs

Medically reviewed on August 23, 2017

Dosage form: tablet, coated
Ingredients: SENNOSIDES A AND B 8.6mg, DOCUSATE SODIUM 50mg
Labeler: NCS HealthCare of KY, Inc dba Vangard Labs
NDC Code: 0615-7773

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Senexon-S Tablets

Active ingredients (in each tablet)

Docusate sodium 50 mg

Sennosides 8.6 mg

Purposes

Stool Softener

Stimulant Laxative 

Uses

• relieves occasional constipation

• generally produces bowel movement in 6 - 12 hours 

Warnings

Do not use  • if you are taking mineral oil     • for longer than one week    • when abdominal pain, nausea or vomiting are present

Ask a doctor before use if you have noticed a sudden change in bowel habits that lasts over two weeks

Ask a doctor or pharmacist before use if you are taking any other drug. Take this product two or more hours before or after other drugs. Laxatives may affect how other drugs work.

Stop use and ask a doctor if   • you have rectal bleeding  • you fail to have a bowel movement after use of this product. 

These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.  In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

• take preferably at bedtime or as directed by a doctor

• if you do not have a comforable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage)

agestarting dosagemaximum dosage
adults and children 12 years and older2 tablets once daily4 tablets twice daily
children 5 to under 12 years1 tablet once daily2 tablets twice daily
children 2 to under 6 years1/2 tablet once daily1 tablet twice daily
children under 2 yearsask a doctorask a doctor

Other Information

• each tablet contains: calcium 20 mg, sodium 6 mg (LOW SODIUM)

• store at 20º - 25ºC (68º - 77ºF) 

Inactive Ingredients

carnauba wax, colloidal silicon dioxide, croscarmellose sodium, D&C yellow #10 aluminum lake, dibasic calcium phosphate dihydrate, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium benzoate, stearic acid, titanium dioxide

Questions or comments?

1-800-645-2158

 Dispense contents with a child-resistant closure in a tight, light-resistant container as defined in the USP.

192R

Distributed by: Rugby Laboratories

31778 Enterprise Drive, Livonia, MI 48150

R-14  Rev. 03/13

Principal Display Panel
SENEXON-S 
docusate sodium-sennosides tablet tablet, coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0615-7773(NDC:0536-4086)
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES A AND B (SENNOSIDES A AND B) SENNOSIDES A AND B8.6 mg
DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM50 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM 
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE 
HYPROMELLOSES 
MAGNESIUM STEARATE 
CELLULOSE, MICROCRYSTALLINE 
CARNAUBA WAX 
SILICON DIOXIDE 
D&C YELLOW NO. 10 
FD&C YELLOW NO. 6 
POLYETHYLENE GLYCOLS 
SODIUM BENZOATE 
STEARIC ACID 
TITANIUM DIOXIDE 
Product Characteristics
ColorORANGEScoreno score
ShapeROUNDSize9mm
FlavorImprint CodeTCL081
Contains    
Packaging
#Item CodePackage Description
1NDC:0615-7773-3131 TABLET, COATED (31 TABLET) in 1 BLISTER PACK
2NDC:0615-7773-3930 TABLET, COATED (30 TABLET) in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart33402/09/2006
Labeler - NCS HealthCare of KY, Inc dba Vangard Labs (050052943)
Establishment
NameAddressID/FEIOperations
NCS HealthCare of KY, Inc dba Vangard Labs050052943RELABEL(0615-7773), REPACK(0615-7773)

 
NCS HealthCare of KY, Inc dba Vangard Labs

← See all SENEXON-S brands

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide